CME vs VRSK vs BGC Stock Comparison

Cme, Verisk Analytics and Bgc Prices as of Nov 13, 2026 Peers: Industry group
CME Cme Group Inc.
$317.97 +11.3% 1M +12.1% 1Y
Market cap
$114.19B
P/E
25.9x
Revenue (TTM)
$6.97B
Div. yield
–
Exchanges Financial Services
4 wins
VRSK Verisk Analytics, Inc.
$207.82 +15.1% 1M -4.5% 1Y
Market cap
$27.53B
P/E
31.3x
Revenue (TTM)
$3.18B
Div. yield
–
Financial Data and Analytics Financial Services
1 win
BGC BGC Group, Inc.
$11.10 -3.6% 1M +22.4% 1Y
Market cap
$5.23B
P/E
22.4x
Revenue (TTM)
$3.39B
Div. yield
0.01%
Institutional Trading Financial Services
6 wins

Head to Head

11 decided of 12

Bgc leads on 6 of the 12 questions below (Bgc 6, Cme 4, Verisk Analytics 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCMEVRSKBGCLeader
Larger companyMarket capitalisation $114.19B $27.53B $5.23B CME
Cheaper on earningsLower P/E, profitable companies only 25.9x 31.3x 22.4x BGC
Cheaper on forward earningsLower price / next fiscal year consensus EPS 27.1x 26.1x 7.9x BGC
Faster revenue growthRevenue growth, trailing twelve months +9.0% +4.9% +22.9% BGC
More profitableNet margin, trailing twelve months 63.3% 27.7% 6.9% CME
Better return on capitalReturn on invested capital 11.7% 31.9% 10.6% VRSK
Less leveragedLower net debt / EBITDA 0.2x 2.3x 1.8x CME
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.01% –
Better 1-year returnPrice return, last 12 months +12.1% -4.5% +22.4% BGC
Better 5-year returnAnnualised price return, 5 years +7.2%/yr -0.8%/yr +17.3%/yr BGC
Less volatileAnnualised volatility, 1 year 25.5% 36.4% 34.5% CME
Higher overall scoreMean of the five percentile scores vs peers 63/100 54/100 66/100 BGC

Percentile Scorecard

CMEVRSKBGC

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCMEVRSKBGC
Valuation 53 #63 of 134 37 #699 of 1108 92 #12 of 134
Growth 30 #59 of 84 40 #540 of 897 75 #22 of 84
Profitability 87 #12 of 88 95 #46 of 922 49 #45 of 88
Financial Health 51 #75 of 151 27 #798 of 1098 37 #96 of 151
Shareholder Returns 92 #5 of 49 70 #230 of 758 75 #13 of 49
Overall 63 54 66
  • CME ranked among 158 companies in Capital Markets
  • VRSK ranked among 1,197 companies in Financial Services
  • BGC ranked among 158 companies in Capital Markets

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCMEVRSKBGCSPY
1 month +11.3%+15.1%-3.6% -2.0%
3 months +17.9%+14.4%-0.9% -2.8%
6 months +6.4%+27.8%-0.8% +2.0%
Year to date +16.4%-7.1%+24.3% +10.6%
1 year +12.1%-4.5%+22.4% +12.2%
3 years +50.2%-12.7%+74.8% +68.1%
3 years, per year +14.5%-4.4%+20.5% +18.9%
5 years +41.4%-3.9%+122.0% +61.4%
5 years, per year +7.2%-0.8%+17.3% +10.1%
10 years +178.0%+150.0%+82.6% +248.5%
10 years, per year +10.8%+9.6%+6.2% +13.3%

Risk

MeasureCMEVRSKBGCSPY
Volatility, 1Y 25.5%36.4%34.5% 13.6%
Downside volatility, 1Y 27.2%36.8%34.4% 13.9%
Beta vs S&P 500, 1Y -0.30-0.580.54 1.00
Return / volatility, 1Y 0.48-0.120.65 0.90
Max drawdown, 5Y -33.1%-51.2%-37.1% -25.4%
From 52-week high -2.6%-7.7%-12.3% -3.2%
52-week high $326.46$225.07$12.65 $779.14
52-week low $218.58$156.84$8.31 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCMEVRSKBGC
P/E now vs peer median 25.8xmedian 42.3x 30.5xmedian 14.9x 22.5xmedian 42.3x
P/S now vs peer median 16.3xmedian 3.9x 8.4xmedian 3.2x 1.5xmedian 3.9x
EV/EBITDA now vs peer median 23.4xmedian 12.7x 17.5xmedian 6.3x 11.5xmedian 12.7x
P/FCF now vs peer median 26.2xmedian 16.5x 24.2xmedian 10.5x 9.5xmedian 16.5x
P/B now vs peer median 4.3xmedian 3.7x -23.9xmedian 1.3x 4.2xmedian 3.7x
PEG now vs peer median 1.88median 0.52 1.20median 0.89 0.19median 0.52

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCMEVRSKBGC
Revenue $6.97B $3.18B $3.39B
Gross profit $1.37B $2.23B –
Operating income $4.58B $1.39B –
Net income $4.42B $879.20M $242.30M
Free cash flow $4.33B $1.10B $552.65M
EPS (diluted) $12.31 $6.80 $0.49
Cash & equivalents $2.20B $556.80M $822.06M
Total debt $3.43B $4.50B $1.78B
Shares (diluted) 358.64M 129.23M 476.33M
Enterprise value $102.53B $23.71B $2.00B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCMEVRSKBGC
P/E 25.8x 30.5x 22.5x
P/FCF 26.2x 24.2x 9.5x
P/Operating cash flow 25.7x 19.5x 8.7x
P/S 16.3x 8.4x 1.5x
P/B 4.3x -23.9x 4.2x
P/Tangible book 4.7x -18.8x 6.1x
EV/EBITDA 23.4x 17.5x 11.5x
EV/EBIT 25.1x 21.9x 13.2x
EV/Revenue 16.5x 9.6x 1.8x
EV/FCF 26.5x 27.8x 11.2x
EV/Operating cash flow 25.9x 22.4x 10.3x
PEG (3Y EPS CAGR) 1.88 1.20 0.19

Growth

14 metrics
MetricCMEVRSKBGC
Revenue growth (1Y) 9.0% 4.9% 22.9%
Revenue CAGR (3Y) 9.2% 6.4% 20.3%
Gross profit growth (1Y) 13.2% 5.7% –
Gross profit CAGR (3Y) 12.5% 7.8% –
Operating income growth (1Y) 10.1% 3.6% –
Operating income CAGR (3Y) 12.2% 6.2% –
Net income growth (1Y) 17.3% -4.6% 49.5%
Net income CAGR (3Y) 13.1% 20.6% 125.6%
EPS growth (1Y) 19.4% 3.3% 47.1%
EPS CAGR (3Y) 13.7% 25.5% 115.9%
Operating cash flow growth (1Y) 6.4% 1.4% 29.2%
Operating cash flow CAGR (3Y) 9.3% 8.9% 22.9%
Free cash flow growth (1Y) 6.1% -1.4% 24.9%
Free cash flow CAGR (3Y) 9.4% 11.0% 21.2%

Profitability

14 metrics
MetricCMEVRSKBGC
Gross margin 19.7% 70.2% –
EBITDA margin 70.4% 55.0% 15.9%
Operating margin 65.7% 43.9% –
Pretax margin 82.8% 36.3% 10.0%
Net margin 63.3% 27.7% 6.9%
FCF margin 62.1% 34.6% 16.3%
Operating cash flow margin 63.5% 43.0% 17.8%
Return on equity 16.6% – 18.4%
Return on assets 2.3% 19.5% 4.1%
Return on invested capital 11.7% 31.9% 10.6%
Return on capital employed 12.3% 40.5% –
Asset turnover 0.0x 0.7x 0.6x
Cash conversion (OCF / net income) 1.0x 1.6x 2.5x
Stock comp / revenue 1.4% 1.9% 9.7%

Financial Health

11 metrics
MetricCMEVRSKBGC
Debt / assets 1.8% 99.0% 30.8%
Debt / equity 0.1x -4.0x 1.4x
Net debt / EBITDA 0.2x 2.3x 1.8x
Debt / FCF 0.8x 4.1x 3.2x
Liabilities / assets 86.2% 124.5% 78.2%
Equity / assets 13.8% -24.5% 21.8%
Interest coverage 26.2x 6.8x 3.6x
Current ratio 1.0x 1.1x –
Quick ratio 0.0x 0.9x –
Cash ratio 0.0x 0.5x –
Altman Z-score 0.59 7.12 –

Shareholder Returns

7 metrics
MetricCMEVRSKBGC
Dividend yield 3.1% 0.9% 0.7%
Net buyback yield – 7.0% 5.8%
Shareholder yield 3.1% 7.9% 6.5%
Payout ratio (earnings) – – 15.9%
Payout ratio (FCF) – – 7.0%
Dividend growth (1Y) – – -1.3%
Dividend CAGR (3Y) – – 34.1%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCMEVRSKBGC
Forward P/E 27.1xFY2026 26.1xFY2026 7.9xFY2026
EPS, next fiscal year $11.75FY2026 $7.96FY2026 $1.40FY2026
EPS growth, next FY +4.9%FY2026 +11.2%FY2026 +18.6%FY2026
EPS growth, the year after +19.3% +5.3% +7.9%
Revenue, next fiscal year $7.27BFY2026 $3.33BFY2026 $3.71BFY2026
Revenue growth, next FY +11.6%FY2026 +8.6%FY2026 +26.0%FY2026
Revenue growth, the year after +7.0% +6.4% -7.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCMEVRSKBGC
Held by institutions 88.9% 97.6% 84.9%
Institutions holding 1,694 956 370
Change in shares held, QoQ +0.4% -0.4% +3.4%
Institutions buying 824 489 214
Institutions selling 656 350 86
Buyers to sellers 1.26 1.40 2.49

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CMEVRSKBGC
CME 1.00 0.23 0.27
VRSK 0.23 1.00 0.11
BGC 0.27 0.11 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CME, VRSK and BGC?

Cme (CME) is the largest by market capitalisation: Cme (CME) $114.19B, Verisk Analytics (VRSK) $27.53B, Bgc (BGC) $5.23B.

Which stock is cheaper, CME, VRSK and BGC?

Bgc (BGC) trades on the lowest price-to-earnings ratio (Cme (CME) 25.9x, Verisk Analytics (VRSK) 31.3x, Bgc (BGC) 22.4x). On next year's consensus earnings, Bgc (BGC) is cheapest (Cme (CME) 27.1x, Verisk Analytics (VRSK) 26.1x, Bgc (BGC) 7.9x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Bgc (BGC) grew revenue fastest over the trailing twelve months: Cme (CME) +9.0%, Verisk Analytics (VRSK) +4.9%, Bgc (BGC) +22.9%.

Which company is more profitable?

Cme (CME) has the highest net margin (Cme (CME) 63.3%, Verisk Analytics (VRSK) 27.7%, Bgc (BGC) 6.9%). On return on invested capital, Verisk Analytics (VRSK) leads (Cme (CME) 11.7%, Verisk Analytics (VRSK) 31.9%, Bgc (BGC) 10.6%).

Which stock has performed better?

Over the past year Bgc (BGC) returned the most: Cme (CME) +12.1%, Verisk Analytics (VRSK) -4.5%, Bgc (BGC) +22.4%. Over five years, Bgc (BGC) compounded fastest (Cme (CME) +7.2%/yr, Verisk Analytics (VRSK) -0.8%/yr, Bgc (BGC) +17.3%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Cme (CME) 0.00%, Verisk Analytics (VRSK) 0.00%, Bgc (BGC) 0.01%. Cme (CME) and Verisk Analytics (VRSK) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Cme (CME) has been the steadiest (Cme (CME) 25.5%, Verisk Analytics (VRSK) 36.4%, Bgc (BGC) 34.5%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CME, VRSK and BGC?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Bgc (BGC) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.